mRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young Adults

Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults and Boost (VXA-CoV2-1.1-S) at 1 Year Post Initial Vaccination in Subset of Subjects

NCT04563702 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection

NCT04645147 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19

NCT04334980 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidates VBI-2902a and VBI-2905a

NCT04773665 ·Status: COMPLETED ·Phase: PHASE1

Phase I Clinical Trial of a Candidate HPV Vaccine

NCT05672966 ·Status: UNKNOWN ·Phase: PHASE1

Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults

NCT02718469 ·Status: COMPLETED ·Phase: PHASE1

A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults

NCT05703607 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19

NCT04619628 ·Status: COMPLETED ·Phase: PHASE1

Study of VXCO-100, a SARS-CoV Candidate Vaccine in Healthy Adults in the United States

NCT05870839 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine

NCT07400003 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Safety, Reactogenicity, and Immunogenicity Trial of STX-S SARS-CoV-2 Vaccine in Adults

NCT07095231 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) Phase III Clinical Trial

NCT05599516 ·Status: UNKNOWN ·Phase: PHASE3

Safety, Reactogenicity and Immunogenicity of a Novel MVA-SARS-2-ST Vaccine Candidate

NCT05226390 ·Status: TERMINATED ·Phase: PHASE1

Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults

NCT04783311 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults

NCT05799651 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Trial to Evaluate Immunogenicity Non-Inferiority, Safety and Lot-to-Lot Consistency of Biovac OCV-S to Euvichol®-Plus

NCT07304284 ·Status: RECRUITING ·Phase: PHASE3

A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccination

NCT05911048 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 50 to 70 Years

NCT06335849 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants

NCT06375512 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects

NCT02370589 ·Status: COMPLETED ·Phase: PHASE1

A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults

NCT04668339 ·Status: TERMINATED ·Phase: PHASE2

A Phase I Clinical Trial to Assess the Safety and Immunogenicity of DX-104

NCT07395739 ·Status: RECRUITING ·Phase: PHASE1

Safety Study of HBV-002 West Nile Vaccine in Healthy Adults

NCT00707642 ·Status: COMPLETED ·Phase: PHASE1

Novartis Vaccine and Diagnostics Carriage Trial

NCT01214850 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901e With E6020 Adjuvant

NCT05614245 ·Status: WITHDRAWN ·Phase: PHASE1